Fredrik Wiklund

1.3k total citations · 1 hit paper
20 papers, 655 citations indexed

About

Fredrik Wiklund is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Genetics. According to data from OpenAlex, Fredrik Wiklund has authored 20 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 3 papers in Genetics. Recurrent topics in Fredrik Wiklund's work include Asthma and respiratory diseases (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers) and Respiratory and Cough-Related Research (6 papers). Fredrik Wiklund is often cited by papers focused on Asthma and respiratory diseases (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers) and Respiratory and Cough-Related Research (6 papers). Fredrik Wiklund collaborates with scholars based in Sweden, Germany and Spain. Fredrik Wiklund's co-authors include Gunilla Telg, Christer Janson, Bright I. Nwaru, Magnus Ekström, Pål Hasvold, Daniel Brattström, Roger Henriksson, Justin P.O. Lindemann, Jonas Bergh and Per‐Ebbe Jönsson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Fredrik Wiklund

18 papers receiving 634 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overuse of short-acting β₂-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme

2020 285 citations Bright I. Nwaru, Magnus Ekström et al. European Respiratory Journal profile →

Peers

Countries citing papers authored by Fredrik Wiklund

Since Specialization

Citations

This map shows the geographic impact of Fredrik Wiklund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fredrik Wiklund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fredrik Wiklund more than expected).

Fields of papers citing papers by Fredrik Wiklund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fredrik Wiklund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fredrik Wiklund. The network helps show where Fredrik Wiklund may publish in the future.

Co-authorship network of co-authors of Fredrik Wiklund

This figure shows the co-authorship network connecting the top 25 collaborators of Fredrik Wiklund. A scholar is included among the top collaborators of Fredrik Wiklund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fredrik Wiklund. Fredrik Wiklund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Early Prostate Cancer Deaths Among Men With Higher vs Lower Genetic Risk 2024 ·JAMA Network Open ·Anna Plym, Yiwen Zhang, Konrad H. Stopsack, (unknown), Tyler M. Seibert, David V. Conti, Christopher A. Haiman, Aris Baras, Tanja Stocks, Isabel Drake, Kathryn L. Penney, Edward L. Giovannucci, Adam S. Kibel, Fredrik Wiklund, Lorelei A. Mucci	7
2	High use of short-acting β₂-agonists in COPD is associated with an increased risk of exacerbations and mortality 2023 ·ERJ Open Research ·Christer Janson, Fredrik Wiklund, Gunilla Telg, Georgios Stratelis, Hanna Sandelowsky	10
3	Annual and Post-Exacerbation Follow-Up of Asthma Patients in Clinical Practice – A Large Population-Based Study in Sweden 2022 ·Journal of Asthma and Allergy ·Hanna Sandelowsky, Björn Ställberg, Fredrik Wiklund, Gunilla Telg, Sofie de Fine Licht, Christer Janson	4
4	Lack of COPD-Related Follow-Up Visits and Pharmacological Treatment in Swedish Primary and Secondary Care 2022 ·International Journal of COPD ·Hanna Sandelowsky, Christer Janson, Fredrik Wiklund, Gunilla Telg, Sofie de Fine Licht, Björn Ställberg	7
5	Short‐acting β₂‐agonist use and asthma exacerbations in Swedish children: A SABINA Junior study 2022 ·Pediatric Allergy and Immunology ·Erik Melén, Bright I. Nwaru, Fredrik Wiklund, Sofie de Fine Licht, Gunilla Telg, Ekaterina Maslova, Ralf J.P. van der Valk, Trung N. Tran, Magnus Ekström, Christer Janson	12
6	Management and Risk of Mortality in Patients Hospitalised Due to a First Severe COPD Exacerbation 2020 ·SHILAP Revista de lepidopterología ·Christer Janson, (unknown), Fredrik Wiklund, Gunilla Telg, Magnus Ekström	0
7	Overuse of short-acting β₂-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme breakdown → 2020 ·European Respiratory Journal ·Bright I. Nwaru, Magnus Ekström, Pål Hasvold, Fredrik Wiklund, Gunilla Telg, Christer Janson	285
8	Real-Life Treatment Patterns and Burden of Disease Among Patients with COPD - A Large Observational Study 2020 ·Claus Vogelmeier, Javier Nuevo, Gunilla Telg, Felix W. Friedrich, (unknown), Fredrik Wiklund, C. Janson	1
9	<p>Management and Risk of Mortality in Patients Hospitalised Due to a First Severe COPD Exacerbation</p> 2020 ·International Journal of COPD ·Christer Janson, Bright I. Nwaru, Fredrik Wiklund, Gunilla Telg, Magnus Ekström	15
10	Risk of Rehospitalization and Death in Patients Hospitalized Due to Asthma 2020 ·The Journal of Allergy and Clinical Immunology In Practice ·Magnus Ekström, Bright I. Nwaru, Fredrik Wiklund, Gunilla Telg, Christer Janson	10
11	Risk of future exacerbations among COPD patients – a real-world register-based cohort study (AvoidEx) 2020 ·Epidemiology ·Claus Vogelmeier, Marc Pignot, Fredrik Wiklund, Javier Nuevo, Gunilla Telg, Christer Janson	3
12	Oral corticosteroid use, morbidity and mortality in asthma: A nationwide prospective cohort study in Sweden 2019 ·Allergy ·Magnus Ekström, Bright I. Nwaru, Pål Hasvold, Fredrik Wiklund, Gunilla Telg, Christer Janson	59
13	Real world utilization of EGFR TKIs and prognostic factors for survival in NSCLC during 2010–2016 in Sweden: A nationwide observational study 2019 ·International Journal of Cancer ·Michael Bergqvist, (unknown), Fredrik Wiklund, Stefan Bergström	17
14	Late Breaking Abstract - SABA overuse and risk of mortality in a nationwide Swedish asthma cohort (HERA) 2019 ·Christer Janson, Bright I. Nwaru, (unknown), Fredrik Wiklund, Gunilla Telg, Magnus Ekström	3
15	Are SABA-reliant asthma patients receiving adequate ICS therapy? A nationwide cohort study in Sweden (HERA) 2019 ·Magnus Ekström, (unknown), (unknown), Fredrik Wiklund, Gunilla Telg, Christer Janson	0
16	Late Breaking Abstract - Oral corticosteroids exposure in a Swedish nationwide asthma population during 2006-2016 2018 ·Bright I. Nwaru, Magnus Ekström, Fredrik Wiklund, Gunilla Telg, (unknown), Christer Janson	1
17	EGFR tyrosine kinase inhibitors in non-small cell lung cancer: Nationwide register-based cohort study in Sweden 2018 ·Annals of Oncology ·Stefan Bergström, (unknown), Fredrik Wiklund, Michael Bergqvist	1
18	FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone As First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer 2012 ·Journal of Clinical Oncology ·Jonas Bergh, Per‐Ebbe Jönsson, Elisabet Lidbrink, Maureen Trudeau, W. Eiermann, Daniel Brattström, Justin P.O. Lindemann, Fredrik Wiklund, Roger Henriksson	197
19	High risk of contralateral breast carcinoma in women with hereditary/familial non‐BRCA1/BRCA2 breast carcinoma 2006 ·Cancer ·(unknown), Monica Emanuelsson, Fredrik Wiklund, Henrik Grönberg	22
20	Prediction of cancer incidence 1998 ·Fredrik Wiklund, Johan Eklund, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact